Active	Status	Sponsor type	Region	Phase	Filter
1 Active 7 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hoemberg, Marc
METRO-NB2012, NCT02641314 / 2011-004593-29: Metronomic Treatment in Children and Adolescents With Recurrent or Progressive High Risk Neuroblastoma	Completed	2	18	Europe	metronomic therapy, Dociton, Celebrex, Endoxan, Lastet, Vinblastinsulfat Teva	University of Cologne	Recurrent Neuroblastoma	06/23	06/23